Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

PARIS (Reuters) - French pharmaceuticals group Sanofi says it will decide shortly whether to seek regulatory approval for dengue vaccine Dengvaxia in the United States, saying it was committed to the medicine despite a health scare in the Philippines.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news